(E)-2-(3-(3-((3-Bromophenyl)amino)-2-cyano-3-oxoprop-1-en-1-yl)-1H-indol-1-yl)acetic acid (1) was discovered in a HTS campaign for CRTh2 receptor antagonists. An SAR around this hit could be established and representatives with interesting activity profiles were obtained. Ring closing tactics to convert this hit series into a novel 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole based CRTh2 receptor antagonist series is presented.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2012.12.050 | DOI Listing |
Publication Analysis
Top Keywords
crth2 receptor
12
receptor antagonists
8
evolution novel
4
novel tricyclic
4
tricyclic crth2
4
antagonists e-2-cyano-3-1h-indol-3-ylacrylamide
4
e-2-cyano-3-1h-indol-3-ylacrylamide scaffold
4
scaffold e-2-3-3-3-bromophenylamino-2-cyano-3-oxoprop-1-en-1-yl-1h-indol-1-ylacetic
4
e-2-3-3-3-bromophenylamino-2-cyano-3-oxoprop-1-en-1-yl-1h-indol-1-ylacetic acid
4
acid discovered
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!